Worldwide Companion Animal Specialty Drugs Industry to 2024 - Key Drivers, Challenges and Trends
Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Global Companion Animal Specialty Drugs Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The companion animal specialty drugs market is poised to grow by $ 2.29 billion during 2020-2024 progressing at a CAGR of 5% during the forecast period.
The reports on companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in pet humanization, rising awareness about disease prevention and pet insurance, and the rise in aging companion animal population.
The companion animal specialty drugs market analysis includes product segment and geographic landscape. This study identifies the enhanced product offerings as one of the prime reasons driving the companion animal specialty drugs market growth during the next few years. Also, an increase in M&A and rising obesity in pets will lead to sizable demand in the market.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
Companies Mentioned
Bayer AG
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals Plc
Elanco Animal Health Inc.
Henry Schein Inc.
Merck & Co. Inc.
Vetoquinol SA
Virbac Group
Zoetis Inc.
The companion animal specialty drugs market covers the following areas:
Companion animal specialty drugs market sizing
Companion animal specialty drugs market forecast
Companion animal specialty drugs market industry analysis
Key Topics Covered:
1. Executive Summary
Market Overview
2. Market Landscape
Market ecosystem
Market characteristics
Value chain analysis
3. Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
4. Five Forces Analysis
Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
5. Market Segmentation by Product
Market segments
Comparison by Product
Vaccines - Market size and forecast 2019-2024
Antibiotics - Market size and forecast 2019-2024
Parasiticides - Market size and forecast 2019-2024
Feed additives - Market size and forecast 2019-2024
Other drugs - Market size and forecast 2019-2024
Market opportunity by Product
6. Market Segmentation by Distribution Channel
Market Segmentation by Distribution Channel
7. Customer Landscape
8. Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
APAC - Market size and forecast 2019-2024
South America - Market size and forecast 2019-2024
MEA - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends
9. Vendor Landscape
Vendor landscape
Landscape disruption
10. Vendor Analysis
Vendors covered
Market positioning of vendors
Bayer AG
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals Plc
Elanco Animal Health Inc.
Henry Schein Inc.
Merck & Co. Inc.
Vetoquinol SA
Virbac Group
Zoetis Inc.
10. Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/4vw3xo
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900